Michael Douglas Taylor, President and CEO at Deciphera Pharmaceuticals, Inc. (DCPH), sold 2,666 shares at $28.00 ($75K) on 2019-02-13, disclosed to the SEC on 2019-02-14.
Open-market sale of $75k DCPH by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| DCPH | SELL | 2021-03-03 | $655K | — | Filing → |
| DCPH | SELL | 2021-02-03 | $687K | — | Filing → |
| DCPH | SELL | 2021-01-06 | $2.1M | — | Filing → |